P&G Finalizes acquisition of Merck Consumer Health

Procter & Gamble (P&G), after completing the acquisition of Merck Consumer Health, starts operations with the P&G brand Health. The transaction was signed in April last year, for a purchase price estimated at R $14.4 billion. With the acquisition, the P&G designs your activity expand segment of non-prescription drugs (MIPs). The portfolio is more than 900 drugs, to combat muscular aches, colds and headaches, as well as products to support mobility and physical activity. Among the flagships in Brazil are the Alginac and the Floratial.